WHO ICTRP trial
Benefits of saline solution inhalation prior to respiratory physiotherapy, in…
EUCTR2020-001026-62-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-001026-62-ES |
|---|---|
| Public title | Benefits of saline solution inhalation prior to respiratory physiotherapy, in patients with bronchiectasis |
| Scientific title | Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial. |
| Primary sponsor | University Hospital Dr Josep Trueta |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Spain |
| Conditions | bronchiectasis MedDRA version: 21.0 Level: PT Classification code 10006445 Term: Bronchiectasis System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases… |
| Interventions | Trade Name: Hypertonic saline solution 7% Pharmaceutical Form: Nebulisation solution INN or Proposed INN: CN 826917 Current Sponsor code: ETGOL PROTOCOL Other descriptive name: SODIUM CHLORIDE SOLUTION 7% Concentration unit: % percent… |
| Registration date | Jun 10, 2021 |
| Target size | 57 |
| Secondary IDs | ETGOL |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: